MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NASH-ADLER, P.
Right arrow Articles by KATZ, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NASH-ADLER, P.
Right arrow Articles by KATZ, A. M.

Molecular Pharmacology, Vol 17, 61-65, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

The Modification of Unidirectional Calcium Fluxes by Dibucaine in Sarcoplasmic Reticulum Vesicles from Rabbit Fast Skeletal Muscle

PRISCILLA NASH-ADLER 1, CHARLES F. LOUIS 1, GARY FUDYMA 1, and ARNOLD M. KATZ 1

1 Division of Cardiology, Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut 06032

The ability of dibucaine to modify unidirectional calcium fluxes was studied in sarcoplasmic reticulum vesicles prepared from rabbit fast skeletal muscle. Dibucaine inhibited initial calcium uptake velocity in a concentration-dependent manner; at 7.4 µM Ca2+, approximately 0.8 mM dibucaine was required to achieve half-maximal inhibition of the calcium pump. This inhibitory effect of dibucaine was increased when external Ca2+ was decreased. Lower dibucaine concentrations (0.08-0.64 mM), however, stimulated calcium uptake when added to calcium-filled vesicles. This stimulatory effect of dibucaine was due to a decrease in the calcium efflux rate of the vesicles. Higher dibucaine concentrations (>0.9 mM) increased calcium efflux and inhibited calcium influx when added to calcium-filled vesicles. These complex effects of dibucaine on calcium transport by the sarcoplasmic reticulum may reflect the ability of this drug to stabilize the membrane at lower concentrations and to disrupt or induce lysis of the membrane at higher concentrations.

Submitted on June 19, 1979
Accepted on August 30, 1979




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics